Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin VB pseudogene 3 (MYO5BP3) is a noncoding segment of DNA derived from the myosin VB gene, classified as a pseudogene. Pseudogenes are typically considered evolutionarily inactive genomic remnants, arising through duplication or retrotransposition events, and lack protein-coding ability. There is no scientific evidence indicating MYO5BP3 is translated into a functional protein or involved in any established cell biological process, nor is it implicated in disease pathways or as a therapeutic target. This distinguishes it from functional myosin V family members (such as MYO5B), which are actin-based motor proteins vital for intracellular transport and membrane trafficking[2][3]. No reference supports a clinical or experimental use for MYO5BP3 or documents drugs that interact with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin VB pseudogene 3 (MYO5BP3).